| 5th Nov 2018 7:00 am |
RNS |
Nominated Adviser Status |
| 3rd Oct 2018 7:00 am |
RNS |
Delivery of Xenon Polariser |
| 23rd Aug 2018 7:00 am |
RNS |
FIRST PATIENT IN PHASE III FDA CLINICAL TRIAL |
| 22nd Aug 2018 7:00 am |
RNS |
Half-year Report |
| 27th Jul 2018 7:00 am |
RNS |
Company update |
| 18th Jul 2018 2:28 pm |
RNS |
Result of AGM |
| 17th Jul 2018 2:49 pm |
RNS |
Holding(s) in Company |
| 10th Jul 2018 3:22 pm |
RNS |
Result of Placing |
| 9th Jul 2018 2:41 pm |
RNS |
Proposed Placing to raise a minimum of £0.78m |
| 21st Jun 2018 10:12 am |
RNS |
Holding(s) in Company |
| 19th Jun 2018 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 19th Jun 2018 4:35 pm |
RNS |
Price Monitoring Extension |
| 19th Jun 2018 7:00 am |
RNS |
Investor Symposium |
| 13th Jun 2018 7:00 am |
RNS |
Final Results |
| 6th Jun 2018 7:00 am |
RNS |
Delivery of Xenon Polariser |
| 31st May 2018 7:00 am |
RNS |
London Investor Symposium |
| 22nd May 2018 7:00 am |
RNS |
Delivery of Xenon Polariser |
| 20th Apr 2018 7:00 am |
RNS |
Grant of Share Options |
| 17th Apr 2018 7:00 am |
RNS |
Polarean technology used in severe asthma study |
| 29th Mar 2018 7:00 am |
RNS |
AIM Admission & First Day of Dealings |
| 29th Mar 2018 7:00 am |
RNS |
Update on Polarean Imaging IPO |
